Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

86.1K
Overview
86.1K
T Cell Types and Functions01:24

T Cell Types and Functions

3.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

2.5K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.5K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

18.0K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
18.0K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

17.3K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
17.3K
Inflammatory Response01:28

Inflammatory Response

18.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
18.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironment.

Oncoimmunology·2016
Same author

Spontaneous presence of FOXO3-specific T cells in cancer patients.

Oncoimmunology·2015
Same author

Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancer.

Oncoimmunology·2015
Same author

Broadening the repertoire of melanoma-associated T-cell epitopes.

Cancer immunology, immunotherapy : CII·2015
Same author

Characterization of Spontaneous Immune Responses against Long Peptides Derived from Bcl-X(L) in Cancer Patients Using Elispot.

Cells·2014
Same author

Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an epitope derived from indoleamine 2,3 dioxygenase.

Clinical cancer research : an official journal of the American Association for Cancer Research·2013

Related Experiment Video

Updated: Mar 28, 2026

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
07:17

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice

Published on: June 22, 2016

10.4K

Cellular immune responses towards regulatory cells.

Stine Kiær Larsen1

  • 1stinekiaer@gmail.com.

Danish Medical Journal
|January 5, 2016
PubMed
Summary
This summary is machine-generated.

This study reveals immune responses against Foxp3 and Foxo3, proteins found in immune-suppressing cells like regulatory T cells (Tregs) and dendritic cells (DCs). These findings suggest a new immunotherapy approach targeting these suppressive cells in cancer.

More Related Videos

Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells
14:23

Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells

Published on: April 16, 2012

25.0K
Mouse Naïve CD4+ T Cell Isolation and In vitro Differentiation into T Cell Subsets
07:12

Mouse Naïve CD4+ T Cell Isolation and In vitro Differentiation into T Cell Subsets

Published on: April 16, 2015

55.0K

Related Experiment Videos

Last Updated: Mar 28, 2026

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
07:17

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice

Published on: June 22, 2016

10.4K
Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells
14:23

Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells

Published on: April 16, 2012

25.0K
Mouse Naïve CD4+ T Cell Isolation and In vitro Differentiation into T Cell Subsets
07:12

Mouse Naïve CD4+ T Cell Isolation and In vitro Differentiation into T Cell Subsets

Published on: April 16, 2015

55.0K

Area of Science:

  • Immunology
  • Cancer Biology
  • Molecular Biology

Background:

  • The tumor microenvironment often contains immune-suppressing cells, such as regulatory T cells (Tregs) and tolerogenic dendritic cells (DCs), which hinder anti-tumor immunity and are linked to poor patient prognosis.
  • Tregs utilize the transcription factor Foxp3 for their development and function, while tolerogenic DCs express Foxo3, programming their immune-suppressive capabilities.

Purpose of the Study:

  • To investigate spontaneous cellular immune responses against the transcription factors Foxp3 and Foxo3.
  • To explore the potential of targeting Foxp3 and Foxo3 as a novel cancer immunotherapy strategy.

Main Methods:

  • Detection of cytotoxic T cells (CTLs) recognizing Foxp3- and Foxo3-derived peptides in cancer patients and healthy donors.
  • Assessment of HLA-A2 restricted T cell recognition of these peptides.
  • Evaluation of Foxp3- and Foxo3-specific CTLs against cancer cell lines and suppressive immune cells (Tregs and DCs).

Main Results:

  • The study identified spontaneous cellular immune responses against Foxp3 and Foxo3 peptides.
  • Cytotoxic T cells recognizing these peptides were detected in cancer patients and healthy donors (for Foxp3).
  • These specific CTLs demonstrated recognition of Foxp3- and Foxo3-expressing cancer cells, Tregs, and in vitro generated DCs.

Conclusions:

  • This research presents the first evidence of immune responses against Foxp3 and Foxo3.
  • The findings support a novel immunotherapy approach by activating the immune system against proteins expressed by immune-suppressive cells.
  • Targeting Foxp3 and Foxo3 offers a potential strategy to overcome immune suppression in the tumor microenvironment.